SpaceX’s IPO may have validated space as an asset class. But the next chapter of the orbital economy could depend on something far less glamorous: standards. 🚀🛰️
Luxembourg-based @exobiosphere, the #space#BioTech#startup working on #drug discovery and #biomedical research in #microgravity, has been awarded €1 million in non-dilutive #funding through the Jeune Entreprise Innovante (JEI) aid scheme. 🇱🇺 🛰️💊
